SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

ZVRA

Zevra Therapeutics, Inc.
NASDAQHealth Care

Latest close: 9.94 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 12, 2026Reported sale · Form 4Neil F. McFarlane, President and CEO · $224.9KOpen the filing ↗
  2. Oct 12, 2026Notice of sale · Form 144NEIL F MCFARLANE · Director, Officer · $227.8KOpen the filing ↗
  3. Aug 14, 2026Reported sale · Form 4Rahsaan Thompson, Chief Legal & Compliance · $474.8KOpen the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record79712 flagged findings
Reported transactions (Form 4)80since Feb 13, 2025 · and 16 other holdings
Corporate events (8-K)30since Jun 1, 2022

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

Identity

Formerly traded as KMPH.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-06capital return (buybacks/dividends)recentOpen filing ↗
    “…(the “Resale Registration Statement”). The Resale Registration Statement was declared effective on April 8, 2024. On June 4,…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 797)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 13, 26Form 144 ↗Notice of proposed sale new
  • Insider transaction · 2 Form 4 filings newshow all 2hide
  • Aug 14, 26Form 144 ↗Notice of proposed sale
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Woodline Partners LP · 8.1% · event on Jun 30, 26 · amendment
  • Aug 12, 26Form 4 ↗Insider transaction
  • Aug 6, 26SCHEDULE 13G/A ↗Passive stake · FMR LLC · 8.3% · event on Jun 30, 26 · amendment
  • Aug 5, 2610-Q ↗Quarterly report
  • Aug 5, 268-K ↗Current report · Results
  • Jul 31, 26SCHEDULE 13G ↗Passive stake · Vanguard Capital Management · 5.1% · event on Jun 30, 26
  • Jul 8, 26Form 144 ↗Notice of proposed sale
  • Insider transaction · 7 Form 4 filingsshow all 7hide
  • Jun 5, 268-K ↗Current report · Shareholder vote results
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • May 11, 26Form 144 ↗Notice of proposed sale
  • May 6, 2610-Q ↗Quarterly report
  • May 6, 268-K ↗Current report · Results
  • May 6, 26SCHEDULE 13G ↗Passive stake · FMR LLC · 5.5% · event on Mar 31, 26

797 filings on record, the oldest from Jan 15, 15.

Listing the 25 most recent filings of the 797 on record.

8-Ks, explained

Stress9Structure59Governance26
  • Mar 16, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Governance4 senior executive changes2025 – 2026show all 4hide
    • Mar 9, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Dec 17, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Dec 2, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Nov 20, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Apr 7, 25StructureCompleted an acquisition or disposal+3 more in the same filing8-K 2.01 ↗
  • Feb 27, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Dec 6, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Jul 12, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Apr 10, 24StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Mar 28, 24StressPast accounts declared unreliable and being restated+2 more in the same filing8-K 4.02 ↗
  • Jan 23, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Nov 20, 23StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
  • Oct 10, 23GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Aug 31, 23StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗

8 older filings not shown · The record reaches back to Jun 26, 15.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

The full record holds 9 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • FMR LLC8.3%Jun 30, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Woodline Partners LP8.1%Jun 30, 26SCHEDULE 13G/A ↗1 earlier filing
  • BlackRock, Inc.7.6%Dec 31, 24SCHEDULE 13G/A ↗
  • Vanguard Capital Management5.1%Jun 30, 26SCHEDULE 13G ↗
  • Nantahala Capital Management, LLC4.4%Dec 31, 24SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
show one more holderhide
  • Adage Capital Management, L.P.4.0%Sep 30, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Oct 12, NEIL F MCFARLANE filed notice of intent to sell up to $228K. That is about 0.03% of shares outstanding. It is filed under a scheduled plan (10b5-1), arranged in advance.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

No sale of theirs is on record yet in Form 4; the 90-day window is still open.

View notice (Form 144) ↗+2 more recent notices · 1 with a later sale

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Oct 12, 26Sell$225KNeil F. McFarlanePresident and CEO↗
  • Aug 14, 26Sell$475KRahsaan ThompsonChief Legal & Compliance↗
  • Aug 10, 26Sell$138KCorey Michael Watton↗
  • Jun 22, 26Sell$438KRahsaan ThompsonChief Legal & Compliance↗
  • May 11, 26Sell$20KRahsaan ThompsonChief Legal & Compliance↗
  • Feb 9, 26Sell$125KNeil F. McFarlanePresident and CEO↗
  • Feb 3, 26Sell$28KTimothy J. SangiovanniSVP, Finance & Corp Controller↗
  • Feb 3, 26Sell$97KJoshua SchaferCCO↗
  • Feb 2, 26Sell$853KNeil F. McFarlanePresident and CEO↗
  • Jan 30, 26Sell$15KTimothy J. SangiovanniSVP, Finance & Corp Controller↗
  • Jan 30, 26Sell$36KRahsaan ThompsonChief Legal & Compliance↗
  • Jan 30, 26Sell$40KAdrian W QuartelChief Medical Officer↗

There are 11 more transactions in this stretch.

Stock compensation, tax and giftsshow the 17 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Oct 10, 26Compensationamount n/aNeil F. McFarlanePresident and CEO↗
  • Aug 10, 26Compensation$61KCorey Michael Watton↗
  • Jun 21, 26Compensationamount n/aRahsaan ThompsonChief Legal & Compliance↗
  • Mar 24, 26Compensation$195KJohn B Bode↗
  • Mar 24, 26Compensation$192KJohn B Bode↗
  • Feb 7, 26Compensationamount n/aNeil F. McFarlanePresident and CEO↗
  • Jan 31, 26Compensationamount n/aNeil F. McFarlanePresident and CEO↗
  • Jan 31, 26Compensationamount n/aTimothy J. SangiovanniSVP, Finance & Corp Controller↗
  • Jan 31, 26Compensationamount n/aJoshua SchaferCCO↗
  • Jan 30, 26Compensationamount n/aTimothy J. SangiovanniSVP, Finance & Corp Controller↗
  • Jan 30, 26Compensationamount n/aRahsaan ThompsonChief Legal & Compliance↗
  • Jan 30, 26Compensationamount n/aAdrian W QuartelChief Medical Officer↗
  • Jan 30, 26Compensationamount n/aJoshua SchaferCCO↗
  • Dec 31, 25Compensationamount n/aR. LaDuane Clifton↗
  • Dec 31, 25Tax$435KR. LaDuane Clifton↗
  • Oct 10, 25Compensationamount n/aNeil F. McFarlanePresident and CEO↗
  • Jun 21, 25Compensationamount n/aRahsaan ThompsonChief Legal & Compliance↗

The full record holds 78 transactions and goes back to Jan 6, 23.

Its sector and its market

Zevra Therapeutics, Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Zevra Therapeutics, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Zevra Therapeutics, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
797 documents on file, from Jan 15, 2015 to Oct 13, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.